Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0OK8N
|
||||
Former ID |
DNC003390
|
||||
Drug Name |
1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551391] | ||
Structure |
Download2D MOL |
||||
Formula |
C10H11N3O3S
|
||||
Canonical SMILES |
CN1C(=CC(=N1)C2=CC=CC=C2)NS(=O)(=O)O
|
||||
InChI |
1S/C10H11N3O3S/c1-13-10(12-17(14,15)16)7-9(11-13)8-5-3-2-4-6-8/h2-7,12H,1H3,(H,14,15,16)
|
||||
InChIKey |
OTZLVSGSRPNRFT-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of Protein tyrosine phosphatase-1B | Target Info | Inhibitor | [551391] | |
KEGG Pathway | Adherens junction | ||||
Insulin signaling pathway | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Cadherin signaling pathway | ||||
Pathway Interaction Database | Insulin Pathway | ||||
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) | |||||
Signaling events mediated by PTP1B | |||||
Calcineurin-regulated NFAT-dependent transcription in lymphocytes | |||||
Signaling events mediated by TCPTP | |||||
IGF1 pathway | |||||
EGF receptor (ErbB1) signaling pathway | |||||
Posttranslational regulation of adherens junction stability and dissassembly | |||||
PDGFR-beta signaling pathway | |||||
N-cadherin signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.